Cannabinoids

US Senate Plans To Delay Ban On Intoxicating Hemp Products

The temporary extension is welcome news

U.S. Senate leaders released a stopgap funding measure on Aug. 2 that includes a provision to postpone the federal government’s forthcoming ban on intoxicating hemp products by a month.

The Senate Appropriations Committee’s Continuing Appropriations and Extensions Act of 2027, known as a continuing resolution (CR), would continue current government funding levels until Dec. 11, 2026, providing lawmakers in Washington additional time to avert a potential shutdown at the end of the fiscal year on Sept. 30.

The Senate’s version of the CR includes a measure to extend certain provisions in the hemp-derived product ban from Nov. 12 to Dec. 11. Specifically, the federal government’s new definition of hemp – that a plant contains no more that 0.3% total THC (including THCA) – and new restriction that products can’t have more than 0.4 milligrams of total THC per container would not be implemented until Dec. 11.

Meanwhile, hemp-derived cannabinoid products containing derivatives that are not capable of being naturally produced by the plant would still be banned on Nov. 12.

The temporary extension is “welcome news” that provides “critical breathing room for hemp farmers, small businesses, retailers, manufacturers and consumers while Congress continues to work toward a long-term solution,” according to the U.S. Hemp Roundtable (USHR).

To Read The Rest Of This Article On Cannabis Business Times, Click Here

Marijuana Retail Report, is a national daily online trade publication serving retailers of marijuana products and accessories. News and information are geared strictly to select retail channels, with distribution limited to licensed collectives, recreational retailers, accessories retailers, and wholesalers.

To Top